Stimulant Meds for ADHD: What are the Risks for Bone Disease?
This well-done retrospective cross-sectional study delivers just what we want from such a study design: a clear path forward to develop a prospective trial to answer a specific question...Investigators looked at data from 6489 children and adolescents in the NHANES database who completed questionnaires and also underwent dual-energy x-ray absorptiometry (DXA) scans. Of those, 159 participants reported use of stimulant medication, presumably for treatment of attention-deficit/hyperactivity disorder (ADHD). They found lower bone density measurements in the stimulant users.
Other Articles in this Edition
Brains of those with ADHD show smaller structures related to emotion
Study: Brain differences found in children with ADHD
ADHD, Asthma Prevalence Tied to Poverty, National Study Shows
Students with special needs get special help behind the wheel
Tiny Babies May Face Mental Health Problems Later
Stimulant Meds for ADHD: What are the Risks for Bone Disease?
Controversial ADHD prescription rule scrapped from Georgia bill